RA
GDRX icon

Royce & Associates’s GoodRx Holdings GDRX Stock Holding History

Royce & Associates’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.7K Buy
38,114
+5,952
+19% +$14K ﹤0.01% 764
2025
Q4 		$87.2K Buy
+32,162
New +$106K ﹤0.01% 753

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Royce & Associates's GDRX Position: Q1 2026 in Review

Royce & Associates increased its GoodRx Holdings (GDRX) stake by 19% in Q1 2026, buying an estimated $14K and bringing the position to 38,114 shares worth $74.7K. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Royce & Associates first reported a position in GDRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $87.2K in Q4 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Royce & Associates held 38,114 shares of GoodRx Holdings worth $74.7K as of Q1 2026.
  • Royce & Associates bought 5,952 GoodRx Holdings shares in Q1 2026, an estimated $14K.
  • GoodRx Holdings made up ﹤0.01% of Royce & Associates's portfolio in Q1 2026, its #764 holding.
  • Royce & Associates first reported a position in GoodRx Holdings in Q4 2025 and has held it in 2 quarters since.
  • Royce & Associates's GoodRx Holdings position peaked at $87.2K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.